on 30 May 2014
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2014 to consider and approve audited annual accounts of the Company for the financial year ended 31 March 2014 on Standalone and Consolidated basis, and to recommend payment of dividend, if any.Powered by Capital Market - Live News